Boston Scientific CorpNYSE:BSX
- LAST PRICE77.0710
- TODAY'S CHANGE (%)-0.3490 (-0.4508%)
- Bid / Lots77.0600/ 3
- Ask / Lots77.0800/ 1
- Open / Previous Close77.4400 / 77.4200
- Day Range
- 52 Week Range
- Volume252,777
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BSX |
|---|---|---|
| 09:32 ET | 57162 | 77.22 |
| 09:34 ET | 9326 | 77.07 |
| 09:36 ET | 4622 | 77.16 |
| 09:38 ET | 7144 | 77.23 |
| 09:39 ET | 6393 | 77.28 |
| 09:41 ET | 15249 | 77.11 |
| 09:43 ET | 5985 | 77.16 |
| 09:45 ET | 10449 | 77.13 |
| 09:48 ET | 11629 | 76.98 |
| 09:50 ET | 3823 | 76.85 |
| 09:52 ET | 8257 | 76.82 |
| 09:54 ET | 5226 | 76.91 |
| 09:56 ET | 3431 | 76.94 |
| 09:57 ET | 2008 | 76.86 |
| 09:59 ET | 1936 | 76.9102 |
| 10:01 ET | 9621 | 77.01 |
| 10:03 ET | 4443 | 76.98 |
| 10:06 ET | 4850 | 77.02 |
| 10:08 ET | 8413 | 77.06 |
| 10:10 ET | 1931 | 77.07 |
| 10:12 ET | 2100 | 77.071 |
May 30, 2024
DJ Boston Scientific Initiated at Buy by Goldman Sachs, from 8:05AM ET on Thursday May 30, 2024 by Dow Jones
8:05AM ET on Thursday May 30, 2024 by Dow Jones
May 28, 2024
DJ Boston Scientific Is Maintained at Buy by Argus Research, from 11:39AM ET on Tuesday May 28, 2024 by Dow Jones
11:39AM ET on Tuesday May 28, 2024 by Dow Jones
May 22, 2024
DJ Boston Scientific Is Maintained at Buy by Citigroup, from 1:33PM ET on Wednesday May 22, 2024 by Dow Jones
1:33PM ET on Wednesday May 22, 2024 by Dow Jones
May 18, 2024
MODULAR ATP Study of the mCRM(TM) System Meets Primary Safety and Efficacy Endpoints, from 11:03AM ET on Saturday May 18, 2024 by Dow Jones
11:03AM ET on Saturday May 18, 2024 by Dow Jones
May 16, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Boston Scientific Corp | 113.4B | 64.4x | -1.29% |
Intuitive Surgical Inc | 148.1B | 75.4x | +9.70% |
Edwards Lifesciences Corp | 53.1B | 36.9x | +14.85% |
GE Healthcare Technologies Inc | 34.8B | 21.8x | --- |
Agilent Technologies Inc | 38.8B | 31.3x | +9.42% |
Koninklijke Philips NV | 25.1B | -27.9x | --- |
Company Information
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. The Cardiovascular segment includes Cardiology and Peripheral Interventions. The Company's Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions.
Contact Information
- Headquarters
- 300 Boston Scientific WayMARLBOROUGH, MA, United States 01752-1291
- Phone
- 508-683-4000
- Fax
- 508-650-8923
Executives
- Chairman of the Board, President, Chief Executive Officer
- Michael Mahoney
- Chief Financial Officer, Executive Vice President
- Daniel Brennan
- Executive Vice President - Human Resources
- Wendy Carruthers
- Executive Vice President, Group President, MedSurg and Asia Pacific
- Arthur Butcher
- Executive Vice President, Group President - Cardiology
- Joseph Fitzgerald
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $113.4B |
|---|---|
Revenue (TTM) | $14.7B |
Shares Outstanding | 1.5B |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.79 |
EPS | $1.20 |
Book Value | $13.16 |
P/E Ratio | 64.4x |
Price/Sales (TTM) | 7.7 |
Price/Cash Flow (TTM) | 38.1x |
Operating Margin | 18.09% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
